Evidence map›Paper›PMID 33283624›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2021

Classification and Grading of Melanocytic Lesions in a Mouse Model of

Charles-Antoine Assenmacher, Sara F Santagostino, Mark A Oyama, Jean-Christophe Marine, Elise Bonvin, Enrico Radaelli

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Charles-Antoine AssenmacherDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA.
Sara F SantagostinoDepartment of Safety Assessment, Genentech, South San Francisco, CA.
Mark A OyamaDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA.
Jean-Christophe MarineLaboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
Elise BonvinLaboratory of Cancer Epigenetics, Cancer Research Center, Université Libre de Bruxelles, Brussels, Belgium.
Enrico RadaelliDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA.
University of Pennsylvania · USTranslational Therapeutics (United States) · USUniversité Libre de Bruxelles · BEVIB-KU Leuven Center for Cancer Biology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mouse line carrying the Tg(Tyr-NRAS*Q61K)1Bee transgene is widely used to model in vivo

Indexed as

Disease Models, AnimalAnimalsBiomarkers, TumorCell ProliferationMelanomaMiceMice, TransgenicMonomeric GTP-Binding ProteinsBiomarkers, TumorMonomeric GTP-Binding ProteinsNras protein, mouseimmunohistochemistrylymph nodesmelanomamiceNRASskin

Identifiers

PMID33283624
PMCPMC7905489
OpenAlexW3111820260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.